VANDA PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 40215
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 15110
 
  
 
C07D HETEROCYCLIC COMPOUNDS 10152
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 6132
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 491
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
C08J WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER- TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C C08F, C08G or C08H 276
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 297
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0304,256 TREATMENT OF CIRCADIAN RHYTHM DISORDERSJul 07, 17Oct 26, 17[A61K, G06F]
2017/0174,617 METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPROPYL]METHYL]PROPANAMIDEMar 02, 17Jun 22, 17[C07C]
2017/0087,123 TREATMENT OF CIRCADIAN RHYTHM DISORDERSDec 14, 16Mar 30, 17[A61K]
2016/0354,337 MELATONIN AGONIST TREATMENTAug 19, 16Dec 08, 16[A61K]
2016/0220,523 TREATING NEURODEGENERATIVE DISEASE WITH FENOFIBRATE AND ANALOGS THEREOFSep 18, 14Aug 04, 16[A61K, G01N]
2016/0213,696 TREATMENT OF CYR61- AND VEGF-MEDIATED CONDITIONSSep 04, 14Jul 28, 16[A61K]
2016/0199,323 CANCER TREATMENTAug 22, 14Jul 14, 16[A61K]
2016/0199,324 MULTIPLE MYELOMA TREATMENTAug 22, 14Jul 14, 16[A61K]
2016/0053,324 METHODS FOR THE ADMINISTRATION OF ILOPERIDONESep 08, 15Feb 25, 16[A61K, C12Q]
2015/0045,390 ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERSMar 14, 13Feb 12, 15[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9855241 Treatment of circadian rhythm disordersDec 14, 16Jan 02, 18[A61K, G01N]
9850199 Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamideMar 02, 17Dec 26, 17[C07C]
RE46604 Treatment of circadian rhythm disordersFeb 24, 16Nov 14, 17[A61K, G01N]
9730910 Treatment of circadian rhythm disordersOct 09, 14Aug 15, 17[A61K, G06F]
9708291 Intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl)-(2-chlorophenyl)-methanoneNov 10, 15Jul 18, 17[C07D]
9617203 Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamideNov 10, 15Apr 11, 17[A61K, C07C]
9549913 Treatment of circadian rhythm disordersJan 25, 13Jan 24, 17[A61K, G01N]
9539234 Treatment of circadian rhythm disordersApr 16, 15Jan 10, 17[A61K, G01N]
9458507 Antipsychotic treatment based on SNP genotypeMar 30, 16Oct 04, 16[A61K, C12Q]
9446038 Method and composition for treating a serotonin receptor-mediated conditionNov 25, 13Sep 20, 16[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0368,718 METHOD OF TREATMENT BASED ON POLYMORPHISMS OF THE KCNQ1 GENEAbandonedSep 01, 15Dec 24, 15[A61K, C12Q]
2015/0259,747 METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATIONAbandonedMay 28, 15Sep 17, 15[A61K, C12Q]
2015/0258,083 METHODS FOR THE ADMINISTRATION OF ILOPERIDONEAbandonedMay 13, 15Sep 17, 15[A61K]
2015/0225,793 METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATIONAbandonedApr 23, 15Aug 13, 15[C12Q, C07D]
2015/0225,794 METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATIONAbandonedApr 23, 15Aug 13, 15[C12Q, C07D]
2015/0225,795 METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATIONAbandonedApr 23, 15Aug 13, 15[C12Q, C07D]
2015/0080,464 MELATONIN AGONIST TREATMENTAbandonedNov 27, 14Mar 19, 15[A61K]
2014/0296,331 TREATMENT OF CIRCADIAN RHYTHM DISORDERSAbandonedJun 11, 14Oct 02, 14[A61K]
2014/0296,332 TREATMENT OF CIRCADIAN RHYTHM DISORDERSAbandonedJun 11, 14Oct 02, 14[A61K]
2014/0045,893 METHODS FOR THE ADMINISTRATION OF ILOPERIDONEAbandonedOct 23, 13Feb 13, 14[A61K]
2014/0039,008 METHODS FOR THE ADMINISTRATION OF ILOPERIDONEAbandonedOct 02, 13Feb 06, 14[C12Q]
8460897 Methods of culturing fungi and producing cellulases and chitinExpiredDec 16, 10Jun 11, 13[C12P, C12N, C07D, C08L]
2012/0136,050 USE OF A MELATONIN AGONIST FOR THE TREATMENT OF SLEEP DISORDERS INCLUDING PRIMARY INSOMNIAAbandonedJul 16, 10May 31, 12[A61K, C07D, A61P]
2011/0172,272 BENZISOXAZOLESAbandonedMar 14, 11Jul 14, 11[A61K, C07D, A61P]
2011/0118,313 IDENTIFICATION OF A MOLECULAR SIGNATURE FOR ANTIPSYCHOTICS AND SERMSAbandonedMay 15, 09May 19, 11[A61K, C12Q, A61P, C40B]
2010/0063,093 METHODS FOR THE ADMINISTRATION OF ILOPERIDONEAbandonedSep 10, 08Mar 11, 10[A61K, C12Q, A61P]
2009/0306,137 TREATMENT FOR DEPRESSIVE DISORDERSAbandonedMay 21, 07Dec 10, 09[A61K, A61P]
2009/0209,638 TREATMENT FOR DEPRESSIVE DISORDERSAbandonedMay 22, 07Aug 20, 09[A61K, A61P]
2009/0105,333 MELATONIN AGONIST TREATMENTAbandonedMay 22, 07Apr 23, 09[A61K, A61P]
2008/0280,954 Method of Improving WakefulnessAbandonedJul 26, 06Nov 13, 08[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.